VTRS Stock Summary and Trading Ideas (Viatris | NASDAQ:VTRS)

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

What symbol and exchange does Viatris shares trade?

Viatris trades on the NASDAQ stock market under the symbol VTRS.

What is Viatris stock price doing today?

As of December 31, 2025, VTRS stock price declined to $12.45 with 6,384,411 million shares trading.

What is Viatris's Beta?

VTRS has a beta of 1.09, meaning it tends to be more sensitive to market movements. VTRS has a correlation of 0.25 to the broad based SPY ETF.

How much is Viatris worth?

VTRS has a market cap of $14.34 billion. This is considered a Large Cap stock.

How much money does Viatris make?

Last quarter Viatris reported $4 billion in Revenue and $.67 earnings per share. This beat revenue expectation by $139 million and exceeded earnings estimates by $.05.

What is the highest and lowest price Viatris traded in the last 3 year period?

In the last 3 years, VTRS traded as high as $13.62 and as low as $6.85.

What are the top ETFs holding Viatris?

The top ETF exchange traded funds that VTRS belongs to (by Net Assets): VTI, VOO, VB, VBR, IVV.

Is Viatris (VTRS) a good investment?

VTRS has underperformed the market in the last year with a return of +4.4%, while SPY returned +17.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in VTRS shares. However, VTRS has outperformed the market in the last 3 month and 2 week periods, returning +27.0% and +8.6%, while SPY returned +2.7% and +0.7%, respectively. This indicates VTRS has been having a stronger performance recently.

What are the support and resistance levels for Viatris (VTRS)?

VTRS support price is $12.33 and resistance is $12.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VTRS shares will trade within this expected range on the day.